Sei Investments CO Tg Therapeutics, Inc. Transaction History

Sei Investments CO

$75 Billion
Q1 2025

A detailed history of Sei Investments CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Sei Investments CO holds 31,852 shares of TGTX stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,852

Previous 29,662 7.38%

Holding current value

$1.14 Million

Previous $1.17 Million 7.36%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$27.67 - $42.99 $60,597 - $94,148	2,190 Added 7.38%	31,852 $1.26 Million
Q1 2025 May 13, 2025	SELL	$27.67 - $42.99 $8,494 - $13,197	-307 Reduced 1.02%	29,662 $1.17 Million
Q4 2024 Feb 11, 2025	SELL	$21.31 - $35.09 $1.31 Million - $2.16 Million	-61,471 Reduced 67.23%	29,969 $902,000
Q3 2024 Nov 12, 2024	BUY	$17.21 - $25.28 $927,326 - $1.36 Million	53,883 Added 143.47%	91,440 $2.14 Million
Q2 2024 Aug 13, 2024	SELL	$13.32 - $19.19 $17,089 - $24,620	-1,283 Reduced 3.3%	37,557 $668,000
Q1 2024 May 07, 2024	BUY	$13.02 - $21.3 $505,696 - $827,292	38,840 New	38,840 $590,000
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $2.54 Million - $5.75 Million	164,243 Added 283.89%	222,097 $5.52 Million
Q1 2023 May 12, 2023	BUY	$10.23 - $19.34 $591,846 - $1.12 Million	57,854 New	57,854 $870,000
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $223,459 - $585,115	-28,612 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $288,207 - $673,305	18,961 Added 196.47%	28,612 $544,000
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $344,559 - $639,919	-15,820 Reduced 62.11%	9,651 $321,000
Q2 2021 Aug 06, 2021	SELL	$32.5 - $48.96 $686,465 - $1.03 Million	-21,122 Reduced 45.33%	25,471 $988,000
Q1 2021 May 12, 2021	BUY	$41.61 - $54.3 $643,290 - $839,478	15,460 Added 49.66%	46,593 $2.32 Million
Q4 2020 Feb 08, 2021	BUY	$25.27 - $54.9 $212,444 - $461,544	8,407 Added 36.99%	31,133 $1.62 Million
Q3 2020 Nov 06, 2020	SELL	$18.49 - $27.24 $65,306 - $96,211	-3,532 Reduced 13.45%	22,726 $608,000
Q2 2020 Aug 11, 2020	BUY	$8.9 - $21.84 $233,696 - $573,474	26,258 New	26,258 $512,000
Q3 2018 Nov 08, 2018	SELL	$5.15 - $14.0 $339 - $924	-66 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$12.5 - $15.0 $275 - $330	22 Added 50.0%	66 $1,000
Q3 2017 Nov 06, 2017	BUY	$10.0 - $12.7 $440 - $558	44	44 $1,000

Others Institutions Holding TGTX

# of Institutions

416

Shares Held

88.1M

Call Options Held

2.34M

Put Options Held

1.94M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.19B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Tg Therapeutics, Inc. Transaction History